CLINICAL_TRIALS
trial_result
· 2022-03-31
Clinical Trial Update: Semaglutide as an Adjunct to Dieting in the Treatment of Type 2 Diabetes [Phase 4]
Summary
Phase 4 clinical trial update evaluating semaglutide as an adjunct to dieting for type 2 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kirsi Pietiläinen | Conditions: Type2 Diabetes | Phase 4 | Status: UNKNOWN